Innovaro Pharmalicensing is a division of Innovaro Europe Ltd
Up-to-date access to technology licensing opportunities worldwide.
Out-licensing Search
Search the Innovaro Pharmalicensing out-licensing directory by keyword. Alternatively our advanced search allows you to query by industry sector, therapeutic target and development phase.
Each Dose of Neo-Penotran® contains a combination of Metronidazole and Miconazole Nitrate in therapeutic concentrations for the local treatment of the treatment three main types of vaginal infections and mixed forms of vaginitis. More
5 and 10 mg Donepezil as well as 4 and 8 mg Ondansetron are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
Amediplase should therefore be an elective drug for early thrombolyisis (even in a pre-hospital setting) with dosing tailored to each single patient, and hence with a reduced risk of severe bleeding as side effects. More
Our patented delivery technology of topical medications - unlike other adhesives - delivers 100% of the active ingredient. In vivo and in vitro trials have proven the superiority of our vehicle to market leaders. More
Rubicon has developed a pleasant tasting, stable sustained release formulation of Dextromethorphan Suspension that has matching dissolution profile with innovator. Use of conventional equipment and technology makes it economical to manufacture. More
All rights reserved. Terms and Conditions | Contact us
